Teriflunomid G.L. Pharma

Teriflunomide G.L. Pharma is an oral medication used to manage certain autoimmune conditions. It belongs to the disease-modifying antirheumatic drug (DMARD) class. This product is manufactured by G.L. Pharma GmbH and is available in the EU. Teriflunomide is prescribed for specific inflammatory disorders.

Teriflunomide is primarily used to treat relapsing forms of multiple sclerosis (MS) and rheumatoid arthritis. It works by modulating the immune system to reduce inflammation and slow disease progression. This medication is often prescribed when other treatments have not been effective. Teriflunomide helps manage symptoms and may reduce flare-ups in autoimmune conditions.

Teriflunomide may help reduce symptoms such as fatigue, muscle weakness, and joint pain associated with autoimmune disorders. Users often report improved mobility and fewer disease flare-ups over time. Some individuals experience mild gastrointestinal effects like nausea or diarrhea when first starting the medication. These effects typically lessen as the body adjusts to the treatment.

Teriflunomide should be taken exactly as prescribed by a healthcare professional. It is important to attend regular medical check-ups while using this medication to monitor its effects. Patients with liver or kidney issues should use this drug with caution. Avoid pregnancy while taking teriflunomide, as it may cause harm to an unborn child.

Teriflunomide can interact with other medications, including certain blood thinners, cholesterol drugs, and vaccines. Combining it with alcohol may increase the risk of liver-related side effects. Always inform your doctor about all medications and supplements you are taking. Live vaccines should be avoided while on teriflunomide therapy.